We are pleased to announce our upcoming event in collaboration with the Health, Innovation and Research Institute UZ Gent (HIRUZ), the Drug Research Unit Ghent (D.R.U.G.), the Safepedrug Clinical Trial Unit (SPD_CTU) and the Women’s Clinic (Vrouwenkliniek). Through this event, we aim to meet our stakeholders and showcase our infrastructure and expertise in clinical trials and drug research at Ghent University Hospital.
Focus of the event
- Presenting the clinical trial infrastructure and expertise at Ghent University Hospital
- Showcasing innovations in early-phase and translational drug research
- Highlighting real-world data and the role of AI in clinical development
- Exploring emerging technologies in gynecology, obstetrics, and reproductive medicine
- Discussing ethical, regulatory, and societal challenges in drug development
- Examining decentralised clinical trials and collaboration models
- Sharing insights from pediatric and adult oncology research
- Celebrating 25 years of the Drug Research Unit Ghent (D.R.U.G.)
Target audience
Physicians, researchers, study coordinators, pharma industry and other professionals interested in drug development and research
Programme
Thursday 23 April 2026
- 12.00 | Registration with light lunch
- 13.00 | Welcome - Prof. Dr. Petra De Sutter, Rector, Ghent University
- 13.15 | Introduction of uterus transplantation from the deceased donor: A multidisciplinary effort - Prof. Dr. Steven Weyers, Ghent University Hospital
- 13.35 | Real-world data: Insights from the GLORIA project - Prof. Dr. Lies Lahousse, CRIG, Ghent University
- 14.05 | ERDERA: solving rare diseases by genomic reanalysis - Prof. Dr. Bruce Poppe, Ghent University Hospital
- 14.35 | Coffee break & visit exhibitors
- 15.05 | From Bench to Baby: Emerging technologies shaping the future of IVF - Prof. Dr. Björn Heindryckx, Ghent University
- 15.25 | Artificial Intelligence from language models to copiloting medicine - Prof. Dr. Steven Callens, Ghent University Hospital
- 15.55 | Current and future ethical challenges in drug development - Prof. Dr. Kasper Raus, Ghent University Hospital
- 16.25 | Wrap up day 1 and closing word - Dr. Philippe Van Rompaey, Ghent University Hospital
- 16.40 | End day 1 & networking drink
Friday 24 April 2026
- 08.30 | Registration with coffee
- 09.00 | Welcome - Prof. Dr. Frank Vermassen, Managing Director, Ghent University Hospital
- 09.15 | Phase I studies in healthy volunteers - Dr. Griet Van Lancker, Ghent University Hospital
- 09.45 | Launch of a UGent/UZGent Centre of Excellence for Clinical pharmacology and Pharmacotherapy - Prof. Dr. Apr. Pieter De Cock, Ghent University & Ghent University Hospital
- 10.15 | Translational PK: Microdialysis, microsampling and tissue PK studies in pediatrics - Dr. Eline Hermans, Ghent University
- 10.45 | Coffee break & visit exhibitors
- 11.15 | Impact of the Clinical Trials Regulation (CTR) and Medical Device Regulation (MDR) - Laura Persijn and Lieselot Burggraeve, Ghent University Hospital
- 11.45 | Developing a National Clinical Trial Network: Lessons from the Trial Nation Model - Kirsten Bødker, Trial Nation Denmark
- 12.15 | When One Isn’t Enough: A Search for Synergy in Rhabdomyosarcoma Therapy - Dr. Deyna Keppens, Ghent University
- 12.45 | Networking lunch & visit exhibitors
- 13.45 | Decentralised Clinical Trials in practice: Experience with ‘flying’ nurses - Eline Van den Bosch, Vaccinopolis, University of Antwerp
- 13.55 | Decentralised Clinical Trials - Prof. Audrey Van Scharen, University Hospital Brussels
- 14.15 | The Pharmacological Revolution in Inflammatory Rheumatic Diseases: Opportunities and Threaths - Prof. Dr. Filip Van den Bosch, Ghent University Hospital
- 14.45 | New developments in the perioperative treatment of bladder cancer - Dr. Camille Berquin, Ghent University Hospital
- 15.05 | Beyond hospital walls: National learning from B.OSS and BAMM - Dr. Griet Vandenberghe, Ghent University Hospital
- 15.25 | D.R.U.G. 25 years: A trip down memory lane - Prof. Dr. Em. Luc Van Bortel, Ghent University
- 15.45 | Wrap up Symposium 2026 and closing word - Prof. Dr. Sylvie Rottey, Ghent University Hospital
- 16.00 | End Symposium 2026 & Farewell reception
Sponsors
Thank you to the sponsors:
- Astellas, Testo, Deltaclinical (gold)
- GSK (silver)
- Amgen, AstraZeneca, BMS, IQVIA, Johnson & Johnson innovative medicine, MSD, Roche (bronze)
Practical information
- The language of the event is English
- Info about the location: www.zebrastraat.be
- Riziv / INAMI accreditation will be requested
- Special thanks to Kinderkankerfonds